← Back to guidelines
Oncology5 papers

Lentigo maligna

Last edited: 4/15/2026

Overview

Lentigo maligna (LM) is a type of melanoma in situ, typically found in sun-damaged skin, particularly on the face and neck, characterized by atypical melanocytic proliferation confined to the epidermis. 2

Diagnosis

  • Clinical examination focusing on atypical pigmented lesions with irregular borders and variable pigmentation.
  • Dermoscopy can aid in distinguishing LM from benign lesions.
  • Histopathological confirmation via biopsy is essential for definitive diagnosis.
  • Awareness of illumination and flash reflex effects during photography can improve diagnostic imaging quality. 2
  • Management

  • First-line treatment: Cryotherapy has shown efficacy but with notable recurrence rates. 1
  • Adjunctive treatments: Further cryotherapy or other interventions may be required for recurrent cases. 1
  • Special Populations

  • No specific data provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts. 12
  • Key Recommendations

  • Cryotherapy can be considered as a first-line treatment for lentigo maligna, though close monitoring for recurrence is necessary. (Evidence: Weak) 1
  • Histopathological confirmation through biopsy is crucial for accurate diagnosis of lentigo maligna. (Evidence: Expert opinion) 2
  • Attention to photographic technique, including illumination and flash reflex, enhances diagnostic accuracy in clinical documentation. (Evidence: Expert opinion) 2
  • References

    1 Collins P, Rogers S, Goggin M, Manning W. Cryotherapy for lentigo maligna. Clinical and experimental dermatology 1991. link 2 Gordon P, Hood C. Lentigo maligna. The Practitioner 1989. link

    Original source

    1. [1]
      Cryotherapy for lentigo maligna.Collins P, Rogers S, Goggin M, Manning W Clinical and experimental dermatology (1991)
    2. [2]
      Lentigo maligna.Gordon P, Hood C The Practitioner (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG